Filter News
Area of Research
News Topics
- (-) Coronavirus (14)
- 3-D Printing/Advanced Manufacturing (27)
- Advanced Reactors (4)
- Artificial Intelligence (15)
- Big Data (11)
- Bioenergy (51)
- Biology (73)
- Biomedical (20)
- Biotechnology (13)
- Buildings (5)
- Chemical Sciences (35)
- Clean Water (14)
- Climate Change (44)
- Composites (11)
- Computer Science (34)
- Critical Materials (13)
- Cybersecurity (5)
- Decarbonization (25)
- Energy Storage (37)
- Environment (101)
- Exascale Computing (6)
- Frontier (6)
- Fusion (8)
- Grid (8)
- High-Performance Computing (24)
- Hydropower (8)
- Irradiation (1)
- Isotopes (13)
- ITER (1)
- Machine Learning (12)
- Materials (78)
- Materials Science (82)
- Mathematics (4)
- Mercury (7)
- Microscopy (34)
- Molten Salt (3)
- Nanotechnology (42)
- National Security (5)
- Net Zero (3)
- Neutron Science (36)
- Nuclear Energy (16)
- Partnerships (12)
- Physics (30)
- Polymers (18)
- Quantum Computing (3)
- Quantum Science (11)
- Renewable Energy (2)
- Security (3)
- Simulation (16)
- Space Exploration (2)
- Summit (11)
- Sustainable Energy (42)
- Transformational Challenge Reactor (3)
- Transportation (15)
Media Contacts
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
When reading the novel Jurassic Park as a teenager, Jerry Parks found the passages about gene sequencing and supercomputers fascinating, but never imagined he might someday pursue such futuristic-sounding science.
Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
A new paper published in Nature Communications adds further evidence to the bradykinin storm theory of COVID-19’s viral pathogenesis — a theory that was posited two years ago by a team of researchers at the Department of Energy’s Oak Ridge National Laboratory.
Researchers from ORNL, the University of Tennessee at Chattanooga and Tuskegee University used mathematics to predict which areas of the SARS-CoV-2 spike protein are most likely to mutate.
Five technologies invented by scientists at the Department of Energy’s Oak Ridge National Laboratory have been selected for targeted investment through ORNL’s Technology Innovation Program.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.